Literature DB >> 15902160

Do alterations in vaginal dimensions after reconstructive pelvic surgeries affect the risk for dyspareunia?

Yoram Abramov1, Sanjay Gandhi, Sylvia M Botros, Roger P Goldberg, Wendi Sherman, Margaret Rurak, Peter K Sand.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether changes in vaginal dimensions after transvaginal reconstructive pelvic surgeries affect the risk for postoperative dyspareunia. STUDY
DESIGN: Charts of all sexually active patients who underwent transvaginal reconstructive pelvic surgeries in our institution between July 1998 and June 2002 with 1 year of follow-up evaluations were reviewed. Data were analyzed with the Student t, chi2, Pearson's correlation tests and a logistic regression model.
RESULTS: Two hundred twenty-eight women aged 44 to 83 years were included. Dyspareunia increased after operation (16% vs 7%; P = .001); total vaginal length (7.6 vs 8.8 cm; P = .001) and genital hiatus (2.7 vs 3.5 cm; P = .001) dimensions significantly decreased after operation, with no predilection for any specific procedure. No correlation was found between these changes in vaginal dimensions and the risk for dyspareunia.
CONCLUSION: The prevalence of dyspareunia increases after transvaginal reconstructive pelvic surgeries. Despite a postoperative decrease in vaginal dimensions, a causal relationship between dyspareunia and changes in vaginal dimensions may not exist.

Entities:  

Mesh:

Year:  2005        PMID: 15902160     DOI: 10.1016/j.ajog.2004.10.628

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Vaginal invagination: definition, clinical presentation and surgical management.

Authors:  Corina Schmid; Peter O'Rourke; Christopher Maher
Journal:  Int Urogynecol J       Date:  2012-06-19       Impact factor: 2.894

2.  Pathophysiology of sexual dysfunction as related to pelvic floor disorders.

Authors:  Lone Mouritsen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

3.  Relationship of postoperative vaginal anatomy and sexual function: a systematic review with meta-analysis.

Authors:  Shunaha Kim-Fine; Danielle D Antosh; Ethan M Balk; Kate V Meriwether; Gregg Kanter; Alexis A Dieter; Mamta M Mamik; Meadow Good; Ruchira Singh; Alexandriah Alas; Mohamed Foda; David D Rahn; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2021-05-14       Impact factor: 2.894

Review 4.  Surgical Repair of the Genital Hiatus: A Narrative Review.

Authors:  Jacqueline Y Kikuchi; Keila S Muñiz; Victoria L Handa
Journal:  Int Urogynecol J       Date:  2021-02-19       Impact factor: 2.894

5.  Vaginal adhesions after transvaginal pelvic reconstructive surgeries: prevalence and clinical implications.

Authors:  Grace Younes; Eyal Goldschmidt; Ariel Zilberlicht; Ron Auslender; Nir Haya; Yoram Abramov
Journal:  Int Urogynecol J       Date:  2015-08-05       Impact factor: 2.894

6.  Trans-umbilical endoscopic cholecystectomy with a water-jet hybrid-knife: a pilot animal study.

Authors:  Sheng-Jun Jiang; Hong Shi; Gyanendra Swar; Hai-Xia Wang; Xiao-Jing Liu; Yong-Guang Wang
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 7.  Pelvic organ prolapse and sexual function.

Authors:  Brigitte Fatton; Renaud de Tayrac; Vincent Letouzey; Stéphanie Huberlant
Journal:  Nat Rev Urol       Date:  2020-06-17       Impact factor: 14.432

8.  Hybrid NOTES transgastric cholecystectomy with reliable gastric closure: an animal survival study.

Authors:  Rogier P Voermans; Mark I van Berge Henegouwen; Willem A Bemelman; Paul Fockens
Journal:  Surg Endosc       Date:  2010-08-19       Impact factor: 4.584

9.  Immediate Postoperative Pelvic Organ Prolapse Quantification Measures and 2-Year Risk of Prolapse Recurrence.

Authors:  Lauren N Siff; Matthew D Barber; Halina M Zyczynski; Charles R Rardin; Sharon Jakus-Waldman; David D Rahn; Ariana L Smith; Donna Mazloomdoost; Amaanti Sridhar; Marie G Gantz
Journal:  Obstet Gynecol       Date:  2020-10       Impact factor: 7.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.